BioSpace News Archive

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced receipt of the Clinical Trial Authorization (CTA) in the UK for the Company’s Cancer Appetite Recovery Study (CAReS).

Grifols has been recognized among the world’s most sustainable companies by the Dow Jones Sustainability Index, the largest global sustainability index and an international benchmark for socially responsible investors.

Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”) , a precision oncology molecular profiling company with a novel phosphoprotein-based laboratory developed test (LDT), today announced its partnership with Perthera , a market leader in Precision Oncology technology and services. The alliance will facilitate and accele

Moberg Pharma’s subsidiary OncoZenge has received binding undertakings regarding a directed issue of shares of SEK 10 million and a fully secured rights issue of shares of approximately SEK 60 million.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based therapeutic formulations and medicines, announced today that it has established a subsidiary, Digestix Bioscience Inc., a company dedicated to the development of medical devices and pharmace

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced its corporate partners, Alphamab Oncology and 3D Medicines, have submitted a new drug applicatio

The French company Diabeloop, a pioneer in therapeutic AI, and Terumo Corporation, a global leader in medical technology, announced that they have signed an agreement for the joint development with exclusive distribution rights in Japan of an automated insulin delivery solution.

Internationally Renowned Med. Dents. and entrepreneurs Golnar and Haleh Abivardi unveil a suite of sustainably produced oral care products supercharged with the first tooth whitener that is actually good for your teeth.

Kadiant, a mission-driven organization that provides high-quality Applied Behavior Analysis (ABA) therapy, speech therapy, diagnostic, and related services to individuals with autism spectrum disorder, announced today that Julie Zhuo has joined the company’s board of directors.

Funding will support research to better understand and address the impact of COVID-19 on children’s mental health